Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Peter J. Leary, Megan Lindstrom, Catherine O. Johnson, et al.
The Lancet Respiratory Medicine (2024)
Open Access | Times Cited: 12

Showing 12 citing articles:

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
Piotr Kędzierski, Marta Banaszkiewicz, Michał Florczyk, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 172-172
Open Access
PULMONARY ARTERIAL HYPERTENSION IN LATIN AMERICA. THE AGE AND COMORBIDITY PARADOX
Tomás Pulido, Sofía De la Cruz‐Pérez, Daphne I Valencia, et al.
International Journal of Cardiology Congenital Heart Disease (2025) Vol. 19, pp. 100573-100573
Open Access
Pulmonary Arterial Hypertension-Induced Reproductive Damage: Effects of Combined Physical Training on Testicular and Epididymal Parameters in Rats
Mírian Quintão Assis, Luciano Bernardes Leite, Luiz Otávio Guimarães Ervilha, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 410-410
Open Access
Epidemiology, Natural History, Humanistic and Economic Burden of Pulmonary Arterial Hypertension in China: A Systematic Literature Review
Caojin Zhang, Helen Ding, Jiahe Li, et al.
Respiratory Medicine (2025), pp. 108007-108007
Open Access
National estimates of mortality of unintentional drowning in China from 1990 to 2021 and its predicted level in the next decade: results from the global burden of disease study 2021
Liuqing You, Jiangmei Liu, Jieming Zhong, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990–2021
Xu Wu, Shuwei Suo, Xian Su, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e095348-e095348
Open Access
MicroRNA-210-5p - a New Druggable Target for Pulmonary Hypertension?
José Alberto Navarro‐García, Anwar Osborne, Xander H.T. Wehrens
Cardiovascular Drugs and Therapy (2025)
Closed Access
Global Landscape of Infection-Induced Pulmonary Hypertension
Ghazwan Butrous
Infectious Disease Reports (2025) Vol. 17, Iss. 2, pp. 35-35
Open Access
The Challenge in Burden of Pulmonary Arterial Hypertension: A Perspective From the Global Burden of Disease Study
Yicheng Yang, Zhiwei Zeng, Qiaoxi Yang, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
Androgen receptor inhibitor ameliorates pulmonary arterial hypertension by enhancing the apoptosis level through suppressing the Notch3/Hes5 pathway
Jiayan Sun, Jiancheng Lin, Di Yin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Therapeutic challenges and new therapeutic targets for combined capillary pulmonary hypertension: a review
Mingjian Lu, Baoguo Wang, Chunyan Rong, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Association between leuko-glycemic index and mortality in critically ill patients with non-traumatic subarachnoid hemorrhage: analysis of the MIMIC-IV database
Hui Shen, Wei Guo, Jin Zhang, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Page 1

Scroll to top